Comparative growth dynamics of bacterial and fungal contaminants in liposomal bupivacaine, bupivacaine 0.5%, and propofol

      Introduction: Bupivacaine liposomal injectable suspension (BLIS) provides local analgesia for up to 72 hours. Multiple vial punctures over consecutive days have been suggested as a cost-effective, extra-label handling strategy. It is unknown, however, if BLIS supports microbial growth when extrinsically contaminated.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Veterinary Anaesthesia and Analgesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect